Literature DB >> 28238547

Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain.

Ira Espuny-Camacho1, Amaia M Arranz2, Mark Fiers1, An Snellinx1, Kunie Ando3, Sebastian Munck4, Jerome Bonnefont5, Laurie Lambot6, Nikky Corthout4, Lorna Omodho1, Elke Vanden Eynden1, Enrico Radaelli1, Ina Tesseur1, Selina Wray7, Andreas Ebneth8, John Hardy7, Karelle Leroy3, Jean-Pierre Brion3, Pierre Vanderhaeghen9, Bart De Strooper10.   

Abstract

Human pluripotent stem cells (PSCs) provide a unique entry to study species-specific aspects of human disorders such as Alzheimer's disease (AD). However, in vitro culture of neurons deprives them of their natural environment. Here we transplanted human PSC-derived cortical neuronal precursors into the brain of a murine AD model. Human neurons differentiate and integrate into the brain, express 3R/4R Tau splice forms, show abnormal phosphorylation and conformational Tau changes, and undergo neurodegeneration. Remarkably, cell death was dissociated from tangle formation in this natural 3D model of AD. Using genome-wide expression analysis, we observed upregulation of genes involved in myelination and downregulation of genes related to memory and cognition, synaptic transmission, and neuron projection. This novel chimeric model for AD displays human-specific pathological features and allows the analysis of different genetic backgrounds and mutations during the course of the disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; cell death; chimeric mouse; dystrophic neurites; expression analysis; human neurons; modeling; neurodegeneration; pluripotent stem cells

Mesh:

Substances:

Year:  2017        PMID: 28238547     DOI: 10.1016/j.neuron.2017.02.001

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  79 in total

Review 1.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

2.  Inhibition of Histone Methyltransferases EHMT1/2 Reverses Amyloid-β-Induced Loss of AMPAR Currents in Human Stem Cell-Derived Cortical Neurons.

Authors:  Lin Lin; Aiyi Liu; Hanqin Li; Jian Feng; Zhen Yan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.

Authors:  Ramsey Najm; Kelly A Zalocusky; Misha Zilberter; Seo Yeon Yoon; Yanxia Hao; Nicole Koutsodendris; Maxine Nelson; Antara Rao; Alice Taubes; Emily A Jones; Yadong Huang
Journal:  Cell Rep       Date:  2020-07-28       Impact factor: 9.423

4.  Neurodegenerative disease: A chimeric approach.

Authors:  Darran Yates
Journal:  Nat Rev Neurosci       Date:  2017-03-17       Impact factor: 34.870

Review 5.  Three-Dimensional Models of the Human Brain Development and Diseases.

Authors:  Mehdi Jorfi; Carla D'Avanzo; Doo Yeon Kim; Daniel Irimia
Journal:  Adv Healthc Mater       Date:  2017-08-28       Impact factor: 9.933

6.  A Mouse Model of Alzheimer's Disease with Transplanted Stem-Cell-Derived Human Neurons.

Authors:  Yuankai Zhu; Hong Zhang
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

Review 7.  Neuronal Cell Death.

Authors:  Michael Fricker; Aviva M Tolkovsky; Vilmante Borutaite; Michael Coleman; Guy C Brown
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise.

Authors:  Yewande Pearse; Michelina Iacovino
Journal:  Med Res Arch       Date:  2020-02-21

Review 9.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

Review 10.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.